Press Releases
BioAsia to promote innovations in Life Science and Healthcare through Start-up Stage in its 17th Edition
Asia's largest Life-sciences and healthcare forum BioAsia, will continue to feature a dedicated platform - Start-up Stage in its 17th edition to be held...
Clinical Trials
Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use
Signant Health announced a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Health’s digital health platform for asthma...
Press Releases
Amgen commences strategic collaboration with BeiGene to expand oncology presence in China
Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand...
News
Catalent Completes Purchase of Biologics Fill-Finish and Oral Solid Dose Facility in Anagni, Italy
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced the...
Clinical Trials
ideaPoint Partners with SAS to Provide Leading Data Sharing Solution Through ClinicalStudyDataRequest.com
Anaqua’s ideaPoint, a leading provider of innovation management solutions, has announced a partnership with SAS, the world leader in analytics. The partnership will provide...
Articles
Drug Substances: Navigating Regulatory Requirements
With a central focus on human safety, high quality standards for drug products are upheld worldwide through various drug agencies. In order to ensure...
Drug Research
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics
Velabs Therapeutics GmbH, a biotech company focused on the rapid screening of functional therapeutic antibodies announced that it has entered into an exclusive licence...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read